Jane Street Group LLC Buys Shares of 10,520 ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

Jane Street Group LLC bought a new position in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned approximately 4.78% of ProShares UltraShort Nasdaq Biotechnology as of its most recent filing with the Securities and Exchange Commission (SEC).

ProShares UltraShort Nasdaq Biotechnology Price Performance

Shares of BIS stock opened at $18.14 on Tuesday. ProShares UltraShort Nasdaq Biotechnology has a twelve month low of $14.05 and a twelve month high of $21.10. The firm has a 50-day moving average price of $16.88 and a 200 day moving average price of $15.81.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The firm also recently declared a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 23rd were paid a dividend of $0.2064 per share. The ex-dividend date was Monday, December 23rd. This is a positive change from ProShares UltraShort Nasdaq Biotechnology’s previous dividend of $0.15.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.